Cladis Investment Advisory LLC Purchases Shares of 1,045 Intuitive Surgical, Inc. $ISRG

Cladis Investment Advisory LLC purchased a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the third quarter, HoldingsChannel.com reports. The firm purchased 1,045 shares of the medical equipment provider’s stock, valued at approximately $467,000.

Several other hedge funds have also recently made changes to their positions in the business. Brighton Jones LLC boosted its position in shares of Intuitive Surgical by 24.9% during the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after purchasing an additional 731 shares in the last quarter. Sivia Capital Partners LLC grew its stake in Intuitive Surgical by 3.8% during the second quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock worth $504,000 after purchasing an additional 34 shares during the period. Schnieders Capital Management LLC. increased its holdings in Intuitive Surgical by 38.0% in the second quarter. Schnieders Capital Management LLC. now owns 973 shares of the medical equipment provider’s stock worth $529,000 after purchasing an additional 268 shares in the last quarter. Moors & Cabot Inc. lifted its stake in Intuitive Surgical by 19.3% in the second quarter. Moors & Cabot Inc. now owns 1,392 shares of the medical equipment provider’s stock valued at $756,000 after buying an additional 225 shares during the period. Finally, Soltis Investment Advisors LLC lifted its stake in Intuitive Surgical by 27.1% in the second quarter. Soltis Investment Advisors LLC now owns 815 shares of the medical equipment provider’s stock valued at $443,000 after buying an additional 174 shares during the period. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Stock Down 1.3%

Shares of NASDAQ:ISRG opened at $490.16 on Friday. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $603.88. The stock’s 50 day moving average is $521.64 and its 200-day moving average is $512.28. The firm has a market capitalization of $174.07 billion, a price-to-earnings ratio of 62.12, a PEG ratio of 3.78 and a beta of 1.66.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.27 by $0.26. The business had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. Intuitive Surgical’s revenue was up 18.8% compared to the same quarter last year. During the same quarter last year, the firm posted $2.21 EPS. Equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts have recently commented on ISRG shares. Barclays set a $712.00 price objective on shares of Intuitive Surgical and gave the stock an “overweight” rating in a research report on Monday, January 26th. TD Cowen raised shares of Intuitive Surgical to a “strong-buy” rating in a research note on Tuesday, January 27th. Wells Fargo & Company raised their price target on shares of Intuitive Surgical from $600.00 to $654.00 and gave the stock an “overweight” rating in a report on Friday, December 12th. Wall Street Zen downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Saturday, February 7th. Finally, Zacks Research upgraded shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a report on Thursday, February 19th. Two investment analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $615.86.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Gary S. Guthart sold 24,500 shares of the firm’s stock in a transaction on Tuesday, January 27th. The shares were sold at an average price of $530.10, for a total value of $12,987,450.00. Following the transaction, the director directly owned 3,694 shares of the company’s stock, valued at approximately $1,958,189.40. This trade represents a 86.90% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Myriam Curet sold 421 shares of Intuitive Surgical stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total transaction of $208,378.16. Following the transaction, the executive vice president owned 409 shares of the company’s stock, valued at $202,438.64. This represents a 50.72% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 37,261 shares of company stock valued at $19,690,721 over the last ninety days. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.